Lanadelumab monoclonal antibody drug. Targets plasma kallikrein; indicated for treatment of hereditary angioedema. Generic name and stylized antibody.


Size: 9000px × 3287px
Photo credit: © molekuul.be / Alamy / Afripics
License: Royalty Free
Model Released: No

Keywords: angioedema, antibody, biological, biosimilar, biotech, biotechnology, breakthrough, disease, drug, hae, hereditary, immunoglobulin, immunology, infusion, injection, inn, kallikrein, kininogen, lanadelumab, mab, monoclonal, nomenclature, peptide, plasma, protein